CN105902907A - Traditional Chinese medicinal composition for treating rosacea - Google Patents
Traditional Chinese medicinal composition for treating rosacea Download PDFInfo
- Publication number
- CN105902907A CN105902907A CN201610254213.6A CN201610254213A CN105902907A CN 105902907 A CN105902907 A CN 105902907A CN 201610254213 A CN201610254213 A CN 201610254213A CN 105902907 A CN105902907 A CN 105902907A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- radix
- chinese medicine
- rosacea
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/904—Stemonaceae (Stemona family), e.g. croomia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/234—Cnidium (snowparsley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicinal composition for treating rosacea. The composition comprises, by weight, 10-30 parts of Yerbadetajo Herb, 10-20 parts of Spica Prunellae, 10-20 parts of Caulis Spatholobi, 5-15 parts of white mulberry root-bark, 10-20 parts of Amur Corktree Bark, 10-20 parts of Hedyotis diffusa, 10-20 parts of Lophatherum gracile, 5-15 parts of mint, 10-20 parts of Sophora flavescens, 10-20 parts of loquat leaves, 10-20 parts of reed rhizome, 10-20 parts of Abrus cantoniensis, 5-15 parts of Rhizoma Homalomenae, 10-20 parts of Fructus Momordicae, 10-20 parts of fructus cnidii, 10-20 parts of Radix Stemonae, 10-20 parts of Cacumen Platycladi, 5-15 parts of dried orange peel, 10-20 parts of Herba Taraxaci, 10-20 parts of radix paeoniae rubra, 10-20 parts of Pseudobulbus Cremastrae seu Pleiones and 5-15 parts of licorice root. The traditional Chinese medicinal composition has the efficacy of nourishing liver and kidney, clearing heat, moistening lung, dissipating binds, eliminating swelling, opening orifice and invigorating blood circulation, has a substantial treatment effect on rosacea, and has reliable effects.
Description
Technical field
The present invention relates to the medicinal preparation not determining structure of a kind of traditional herbal medicines, a kind of Chinese medicine composition treating rosacea.
Background technology
Acne rosacea is a kind of rubescent with nose, upper pimpling, pustule and telangiectasis, the dermatosis that likeness in form Fructus Fragariae Ananssae or well-done Fructus Lycopersici esculenti are characterized.Often send out in middle age, be apt to occur in the middle part of face, nose and dilator naris, also can extend to and two cheeks, jaw portion and forehead.Slight rosacea patient only has telangiectasis, local skin flushing, and oils and fats is many, and then may occur in which red little pimple, pustule.Severe rosacea patient's nose is loose, hair follicle is trembled out and formed pachydermatosis.At present, clinical treatment rosacea selects the antibiotic such as metronidazole, tetracycline, clarithromycin；To antibiotic therapy nonresponder, can low dose of oral isotretinoin；To severe rosacea patient in menopause, also there is certain curative effect with estrin treatment.But its treatment rosacea curative effect is unsatisfactory, and side effect is big.
The traditional Chinese medical science is thought, rosacea is many to be steamed by lung meridian heat in blood, secondary chance the exterior tightened by pathogenic windcold, and blood stasis stagnates caused.
According to theory of Chinese medical science, for the pathogeny of rosacea, with clearing heat and moistening lung, sensible invigorate blood circulation as the rule for the treatment of, carry out dialectical composition of prescription, to reach the purpose for the treatment of both the principal and secondary aspects of a disease.
Summary of the invention
Prior art uses Tri-Biocin treatment rosacea there is the deficiency that curative effect is undesirable, side effect is big to overcome, the present invention provide a kind of prepare conveniently, medicine source is wide, low cost, evident in efficacy, reliable effect, the Chinese medicine composition for the treatment of rosacea having no side effect.
nullThe technical solution adopted for the present invention to solve the technical problems is: a kind of Chinese medicine composition treating rosacea，It is characterized in that: its raw material of Chinese medicine and weight be: Herba Ecliptae 10-30 part，Spica Prunellae 10-20 part，Caulis Spatholobi 10-20 part，Cortex Mori 5-15 part，Cortex Phellodendri 10-20 part，Herba Hedyotidis Diffusae 10-20 part，Herba Lophatheri 10-20 part，Herba Menthae 5-15 part，Radix Sophorae Flavescentis 10-20 part，Folium Eriobotryae 10-20 part，Rhizoma Phragmitis 10-20 part，Herba Abri 10-20 part，Rhizoma Homalomenae 5-15 part，Fructus Momordicae 10-20 part，Fructus Cnidii 10-20 part，Radix Stemonae 10-20 part，Cacumen Platycladi 10-20 part，Pericarpium Citri Reticulatae 5-15 part，Herba Taraxaci 10-20 part，Radix Paeoniae Rubra 10-20 part，Pseudobulbus cremastrae seu pleiones 10-20 part，Radix Glycyrrhizae 5-15 part.
The preferred technical solution of the present invention is: a kind of Chinese medicine composition treating rosacea, it is characterised in that: its raw material of Chinese medicine and weight be: Herba Ecliptae 20 parts, Spica Prunellae 15 parts, Caulis Spatholobi 15 parts, Cortex Mori 10 parts, Cortex Phellodendri 15 parts, Herba Hedyotidis Diffusae 15 parts, Herba Lophatheri 15 parts, Herba Menthae 10 parts, Radix Sophorae Flavescentis 15 parts, Folium Eriobotryae 15 parts, Rhizoma Phragmitis 15 parts, Herba Abri 15 parts, Rhizoma Homalomenae 10 parts, Fructus Momordicae 15 parts, Fructus Cnidii 15 parts, the Radix Stemonae 15 parts, Cacumen Platycladi 15 parts, Pericarpium Citri Reticulatae 10 parts, Herba Taraxaci 15 parts, Radix Paeoniae Rubra 15 parts, Pseudobulbus cremastrae seu pleiones 15 parts, 10 parts of Radix Glycyrrhizae.
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience instruct, selected medicament composing prescription.In Chinese medicine composition of the present invention: Herba Ecliptae has effect of nourishing the liver and kidney, cooling blood for hemostasis；Spica Prunellae has effect of liver heat removing and eyesight improving, clearing away heat and promoting diuresis, mass dissipating and swelling eliminating；Caulis Spatholobi has replenishing and activating blood, relaxes through effect of dredging collateral；Cortex Mori has effect of eliminating pathogen from the lung for relieving asthma, inducing diuresis to remove edema；Cortex Phellodendri has heat clearing and damp drying, pathogenic fire purging except steaming, effect of detoxification sore treatment；Herba Hedyotidis Diffusae has effect of heat-clearing and toxic substances removing, inducing diuresis to remove edema, promoting blood circulation and stopping pain；Herba Lophatheri has effect of clearing heat and relieving fidgetness, diuresis；Herba Menthae has dispelling wind and heat pathogens, clear profit removing toxic substances, effect of dispersing the stagnated live-QI to relieve the stagnation of QI；Radix Sophorae Flavescentis has effect of heat clearing and damp drying, wind dispelling insecticide；Folium Eriobotryae has effect of clearing away lung-heat to relieve cough, stopping nausea and vomiting by lowering the adverse flow of QI；Rhizoma Phragmitis has effect of clearing away heat and promoting production of body fluid, relieving restlessness, preventing or arresting vomiting, diuresis；Herba Abri has effect of blood circulation promoting and blood stasis dispelling, inducing diuresis for treating stranguria syndrome, clearing away heat and expelling pathogen in the exterior；Rhizoma Homalomenae has effect of wind-damp dispelling, relaxing muscles and tendons and activating QI and blood in the collateral, alleviating pain and detumescence；Fructus Momordicae has clearing heat and moistening lung, effect of laxation relieving constipation；Fructus Cnidii has effect of warming the kidney to invigorate YANG, expelling wind and cold, removing dampness and killing parasites；The Radix Stemonae has effect of nourishing the lung to keep the adverse QI downward, cough-relieving, parasite killing；Cacumen Platycladi has cooling blood for hemostasis, eliminating phlegm and stopping cough, wind-damp dispelling, effect of scattered toxic swelling；Pericarpium Citri Reticulatae has diuretic, effect of drying dampness to eliminate phlegm in regulating qi-flowing for strengthening spleen, tune；Herba Taraxaci has effect of heat-clearing and toxic substances removing, dispersing swelling and dissipating binds, inducing diuresis for treating stranguria syndrome；Radix Paeoniae Rubra has effect of clearing away heat and cooling blood, eliminating stasis to stop pain；Pseudobulbus cremastrae seu pleiones has effect of heat-clearing and toxic substances removing, relieving sore throat and pain；Radix Glycyrrhizae has effect of invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, coordinating the actions of various ingredients in a prescription.Drug component in the present composition, through dialectical compatibility, complements each other using, and has synergism, plays nourishing the liver and kidney, clearing heat and moistening lung, mass dissipating and swelling eliminating, sensible effect invigorated blood circulation altogether, rosacea reaches the purpose for the treatment of both the principal and secondary aspects of a disease.
The component of the present composition all uses natural raw material of Chinese medicine, and its preparation is easy, medicine source is wide, low cost.It follows the prescriptions principle of the traditional Chinese medical science, and various component drug use the use that is decocted in water for oral dose.Verifying by clinic application, it is evident in efficacy, reliable effect, mild in medicine property and, toxic and side effects does not occurs, total effective rate 93.75%, cure rate reaches 67.5%.
Detailed description of the invention
Below in conjunction with embodiment, the present invention will be further described.
Embodiment 1
A kind of Chinese medicine composition treating rosacea, its raw material of Chinese medicine and weight proportion be: Herba Ecliptae 20g, Spica Prunellae 15g, Caulis Spatholobi 15g, Cortex Mori 10g, Cortex Phellodendri 15g, Herba Hedyotidis Diffusae 15g, Herba Lophatheri 15g, Herba Menthae 10g, Radix Sophorae Flavescentis 15g, Folium Eriobotryae 15g, Rhizoma Phragmitis 15g, Herba Abri 15g, Rhizoma Homalomenae 10g, Fructus Momordicae 15g, Fructus Cnidii 15g, Radix Stemonae 15g, Cacumen Platycladi 15g, Pericarpium Citri Reticulatae 10g, Herba Taraxaci 15g, Radix Paeoniae Rubra 15g, Pseudobulbus cremastrae seu pleiones 15g, Radix Glycyrrhizae 10g.
Embodiment 2
A kind of Chinese medicine composition treating rosacea, its raw material of Chinese medicine and weight proportion be: Herba Ecliptae 10g, Spica Prunellae 20g, Caulis Spatholobi 10g, Cortex Mori 15g, Cortex Phellodendri 10g, Herba Hedyotidis Diffusae 20g, Herba Lophatheri 10g, Herba Menthae 15g, Radix Sophorae Flavescentis 10g, Folium Eriobotryae 20g, Rhizoma Phragmitis 10g, Herba Abri 20g, Rhizoma Homalomenae 5g, Fructus Momordicae 20g, Fructus Cnidii 10g, Radix Stemonae 20g, Cacumen Platycladi 10g, Pericarpium Citri Reticulatae 15g, Herba Taraxaci 10g, Radix Paeoniae Rubra 20g, Pseudobulbus cremastrae seu pleiones 10g, Radix Glycyrrhizae 15g.
Embodiment 3
A kind of Chinese medicine composition treating rosacea, its raw material of Chinese medicine and weight proportion be: Herba Ecliptae 30g, Spica Prunellae 10g, Caulis Spatholobi 20g, Cortex Mori 5g, Cortex Phellodendri 20g, Herba Hedyotidis Diffusae 10g, Herba Lophatheri 20g, Herba Menthae 5g, Radix Sophorae Flavescentis 20g, Folium Eriobotryae 10g, Rhizoma Phragmitis 20g, Herba Abri 10g, Rhizoma Homalomenae 15g, Fructus Momordicae 10g, Fructus Cnidii 20g, Radix Stemonae 10g, Cacumen Platycladi 20g, Pericarpium Citri Reticulatae 5g, Herba Taraxaci 20g, Radix Paeoniae Rubra 10g, Pseudobulbus cremastrae seu pleiones 20g, Radix Glycyrrhizae 5g.
Embodiment 4
A kind of Chinese medicine composition treating rosacea, its raw material of Chinese medicine and weight proportion be: Herba Ecliptae 15g, Spica Prunellae 18g, Caulis Spatholobi 12g, Cortex Mori 13g, Cortex Phellodendri 12g, Herba Hedyotidis Diffusae 18g, Herba Lophatheri 12g, Herba Menthae 13g, Radix Sophorae Flavescentis 12g, Folium Eriobotryae 18g, Rhizoma Phragmitis 12g, Herba Abri 18g, Rhizoma Homalomenae 8g, Fructus Momordicae 18g, Fructus Cnidii 12g, Radix Stemonae 18g, Cacumen Platycladi 12g, Pericarpium Citri Reticulatae 13g, Herba Taraxaci 12g, Radix Paeoniae Rubra 18g, Pseudobulbus cremastrae seu pleiones 12g, Radix Glycyrrhizae 13g.
Embodiment 5
A kind of Chinese medicine composition treating rosacea, its raw material of Chinese medicine and weight proportion be: Herba Ecliptae 25g, Spica Prunellae 12g, Caulis Spatholobi 12g, Cortex Mori 8g, Cortex Phellodendri 18g, Herba Hedyotidis Diffusae 12g, Herba Lophatheri 18g, Herba Menthae 8g, Radix Sophorae Flavescentis 18g, Folium Eriobotryae 12g, Rhizoma Phragmitis 18g, Herba Abri 12g, Rhizoma Homalomenae 13g, Fructus Momordicae 12g, Fructus Cnidii 18g, Radix Stemonae 12g, Cacumen Platycladi 18g, Pericarpium Citri Reticulatae 8g, Herba Taraxaci 18g, Radix Paeoniae Rubra 12g, Pseudobulbus cremastrae seu pleiones 18g, Radix Glycyrrhizae 8g.
Chinese medicine composition in embodiment of the present invention decocting method routinely produces medicament.Concrete grammar is as follows: put in container by the raw material of Chinese medicine of prescription, adds cold water and covers powder, soak 15～20 minutes, added water no powder about 8 centimetres, carries out decocting for the first time, at a simmer before use intense fire to decoct, with slow fire boiling 20～30 minutes after boiling；Second time decocts, and added water no powder about 5 centimetres, decocts 15～20 minutes after water boiling.Twice decoction is removed slag extracting juice, merges.
The present invention, with a kind of Chinese medicine composition treating rosacea given by embodiment 1, does clinical efficacy and is summarized as follows:
One, general data: Chinese medicine composition of the present invention is applied to clinical observation 80 cases, the maleest 31 examples, female 49 example, age 25～60 years old.
Two, diagnostic criteria:
1, multiple middle age of being born in, women is more, is often accompanied by seborrhea；
2, sending out in the middle part of face, especially nose, the wing of nose are very, and secondary is two cheeks and forehead；
3, skin lesion feature is mainly pimple, pustule, erythema, accompanies telangiectasis；Its evolution is followed successively by erythema phase, papulopustule phase, pachydermatosis phase, but three phases are without obvious boundary；
4, no conscious sympton；
5, morbidity is slowly, and prolonged difficulty is more.
Three, usage and dosage: during clinical practice, one day potion, decocting twice extracting juice about 300ml, point early, late twice warm is taken, and within ten days, is a course for the treatment of.Take medicine period avoid eating anything raw or cold, pungent thing.
Four, criterion of therapeutical effect:
1, recovery from illness: erythra (such as erythema, pimple, pustule etc.) is wholly absent, subjective symptoms disappears, and skin color recovers normal, occurs without new rash；
2, effective: deflorescence is more than 70%, and new rash occurs less, and flushing goes down；Skin still has slight erythema, or the little pimple of minority；
3, effective: skin symptom (such as erythema, pimple, pustule etc.) has alleviated；
4, invalid: symptom, without taking a turn for the better, is even aggravated, flushing still, still has new rash to occur, sometimes has concurrently and ooze out, pain and swelling.
Five, therapeutic effect: in this clinical observation case, take medicine 2-10 the course for the treatment of, 54 examples of fully recovering, effective 13 examples, effective 8 examples, invalid 5 examples.Toxic and side effects is there is not during treatment.
Six, model case:
Case 1: beam, female, 27 years old.Time medical, readme initiates nose flushing repeatedly, increases to two cheeks, glabella, chin portion later, symmetrical, is drinking, is eating peppery rear outbreak, skin greasing.After 2 courses for the treatment of of medicament taking prepared by the Chinese medicine composition of the present invention, flushing disappears；Consolidate and take 2 courses for the treatment of, transference cure, cure.Follow up a case by regular visits to half a year without recurrence.
Case 2: week certain, man, 39 years old, readme from the beginning of time nose recurrent exerbation purple skin lesion, after be extended down to glabella and two cheeks, and no longer disappear, and deteriorate into rapidly pimple pustule.After 3 courses for the treatment of of medicament taking prepared by the Chinese medicine composition of the present invention, pimple pustule disappears, purple skin lesion color dodge；Continuing after taking 2 courses for the treatment of, skin lesion color recovers normal；Consolidate after taking 1 course for the treatment of, cure.Follow up a case by regular visits to half a year without recurrence.
Claims (2)
1. the Chinese medicine composition treating rosacea, it is characterized in that: its raw material of Chinese medicine and weight be: Herba Ecliptae 10-30 part, Spica Prunellae 10-20 part, Caulis Spatholobi 10-20 part, Cortex Mori 5-15 part, Cortex Phellodendri 10-20 part, Herba Hedyotidis Diffusae 10-20 part, Herba Lophatheri 10-20 part, Herba Menthae 5-15 part, Radix Sophorae Flavescentis 10-20 part, Folium Eriobotryae 10-20 part, Rhizoma Phragmitis 10-20 part, Herba Abri 10-20 part, Rhizoma Homalomenae 5-15 part, Fructus Momordicae 10-20 part, Fructus Cnidii 10-20 part, Radix Stemonae 10-20 part, Cacumen Platycladi 10-20 part, Pericarpium Citri Reticulatae 5-15 part, Herba Taraxaci 10-20 part, Radix Paeoniae Rubra 10-20 part, Pseudobulbus cremastrae seu pleiones 10-20 part, Radix Glycyrrhizae 5-15 part.
A kind of Chinese medicine composition treating rosacea the most according to claim 1, it is characterised in that: its raw material of Chinese medicine and weight be: Herba Ecliptae 20 parts, Spica Prunellae 15 parts, Caulis Spatholobi 15 parts, Cortex Mori 10 parts, Cortex Phellodendri 15 parts, Herba Hedyotidis Diffusae 15 parts, Herba Lophatheri 15 parts, Herba Menthae 10 parts, Radix Sophorae Flavescentis 15 parts, Folium Eriobotryae 15 parts, Rhizoma Phragmitis 15 parts, Herba Abri 15 parts, Rhizoma Homalomenae 10 parts, Fructus Momordicae 15 parts, Fructus Cnidii 15 parts, the Radix Stemonae 15 parts, Cacumen Platycladi 15 parts, Pericarpium Citri Reticulatae 10 parts, Herba Taraxaci 15 parts, Radix Paeoniae Rubra 15 parts, Pseudobulbus cremastrae seu pleiones 15 parts, 10 parts of Radix Glycyrrhizae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610254213.6A CN105902907A (en) | 2016-04-23 | 2016-04-23 | Traditional Chinese medicinal composition for treating rosacea |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610254213.6A CN105902907A (en) | 2016-04-23 | 2016-04-23 | Traditional Chinese medicinal composition for treating rosacea |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105902907A true CN105902907A (en) | 2016-08-31 |
Family
ID=56751774
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610254213.6A Pending CN105902907A (en) | 2016-04-23 | 2016-04-23 | Traditional Chinese medicinal composition for treating rosacea |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105902907A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103638376A (en) * | 2013-11-21 | 2014-03-19 | 山东中大药业有限公司 | Traditional Chinese medicine tablet for treating rosacea |
| CN103638377A (en) * | 2013-11-21 | 2014-03-19 | 山东中大药业有限公司 | Traditional Chinese medicine pill for treating rosacea |
| CN104042896A (en) * | 2014-07-06 | 2014-09-17 | 朱克兰 | Traditional Chinese medicinal composition for treating rosacea |
-
2016
- 2016-04-23 CN CN201610254213.6A patent/CN105902907A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103638376A (en) * | 2013-11-21 | 2014-03-19 | 山东中大药业有限公司 | Traditional Chinese medicine tablet for treating rosacea |
| CN103638377A (en) * | 2013-11-21 | 2014-03-19 | 山东中大药业有限公司 | Traditional Chinese medicine pill for treating rosacea |
| CN104042896A (en) * | 2014-07-06 | 2014-09-17 | 朱克兰 | Traditional Chinese medicinal composition for treating rosacea |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103386008B (en) | Chinese medicine composition for treating endocrine dyscrasia | |
| CN103330805B (en) | Traditional Chinese medicine composition for treating menorrhagia | |
| CN104107395A (en) | Traditional Chinese medicine composition for treating endocrine dyscrasia | |
| CN103055116B (en) | Traditional Chinese medicine composition for treating acnes | |
| CN104606470A (en) | Traditional Chinese medicine composition for treating endocrine dyscrasia | |
| CN103272143A (en) | Traditional Chinese medicine composition for treating acne | |
| CN103211990A (en) | Chinese medicinal composition for treating oral ulcer | |
| CN105749167A (en) | Traditional Chinese medicine composition for treating amenorrhea | |
| CN104587385A (en) | Traditional Chinese medicine composition for treating blood stasis condensation type rosacea | |
| CN103705898A (en) | Traditional Chinese medicine composition for treating acnes | |
| CN103690925A (en) | Traditional Chinese medicinal composition for treating amenorrhea | |
| CN103272129B (en) | Traditional Chinese medicine composition for treating neurodermatitis | |
| CN106075268A (en) | A kind of Chinese medicine composition treating scabies | |
| CN105902907A (en) | Traditional Chinese medicinal composition for treating rosacea | |
| CN105920541A (en) | Traditional Chinese medicinal composition for treating tinea versicolor | |
| CN105920292A (en) | Chinese medicinal composition for treating acute mastitis | |
| CN105833152A (en) | Traditional Chinese medicine composition for treating endocrine dyscrasia | |
| CN105797021A (en) | Traditional Chinese medicinal composition for treating acne | |
| CN105998738A (en) | Traditional Chinese medicinal composition for treating night sweat | |
| CN105770427A (en) | Traditional Chinese medicine composition for treating oligospermia and asthenozoospermia | |
| CN105687899A (en) | Traditional Chinese medicine composition for treating senile plaques | |
| CN104587397A (en) | Traditional Chinese medicinal composition for treating endocrine dyscrasia | |
| CN103784929A (en) | Traditional Chinese medicine composition for treating irregular menstruation | |
| CN105853783A (en) | Traditional Chinese medicinal composition for treating rosacea | |
| CN105833095A (en) | Traditional Chinese medicine composition for treating hordeolum |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160831 |
|
| WD01 | Invention patent application deemed withdrawn after publication |